ClinicalTrials.gg
Status unknownNCT05294133Updated Apr 5, 2022

Implementation of a 12-week Adapted Physical Activity (APA) Program in People Suffering From Chronic Insomnia.

An interventional study of physical activity in Exercise, Health Behavior and Sleep, sponsored by Universite du Littoral Cote d'Opale. Status unknown at 1 site in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-04-05.

Primary conditionHealth BehaviorRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Health Behavior
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Health Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universite du Littoral Cote d'Opale · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2021, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 16 studies in Health Behavior with a site in France — 8 open to participants now, 8 under way, none of them phase 3. Health Behavior · France.

Started
2021
with 3 others
No phase
9 of 16
6 open now
Registered
7th of 16
by date
Lead sponsor
1 of 16
Universite du Littoral Cote d'Opale

Among the 16 studies in Health Behavior with a site in France, this one is one of 4 that started in 2021, is one of 9 with no phase, and was the 7th registered.

Health Behavior

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

Browse Health Behavior studies →

Open to participants now

8 of the 16 studies in Health Behavior with a site in France are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 93 Health Behavior studies recruiting now, 39 (42%) set no upper age limit and 37 (40%) stop at 75 or younger; 25 take children under 18; 58 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Health Behavior with a site in France, or all of them as a file.
02

Study summary

One third of men and women are not satisfied with their sleep. A non-drug countermeasure to improve sleep in insomniacs could be adapted physical activity (APA). However, research is needed because the literature is limited and the few studies are most often based on subjective data with a great methodological disparity. Within the framework of the care pathway of Dr ARON's patients, sleep doctor at the Sommeil Morphée Center of the Grande Synthe Polyclinic (59), the objective of this project is to make an APA program more reliable in order to improve sleep, to understand the underlying mechanisms and to include APA in the therapeutic management.

Read the detailed description

According to the 2019 National Sleep and Vigilance Institute survey, in France, one-third of men and women are not satisfied with their sleep, and nearly half struggle to fall asleep or return to sleep. Given the growing evidence of the harmful effects of lack of sleep, its alteration on health, these figures are alarming.

Insomnia is characterized by dissatisfaction with the quantity or quality of sleep, difficulty initiating and/or maintaining sleep, and early morning awakenings at least three times a week for a minimum period of three months.

In a Sleep Medicine Reviews report, it was shown that many patients diagnosed with insomnia had a physiological hyperarousal disorder that resulted in poor sleep, which has been found in insomniacs in numerous studies. It is observed in particular on the autonomic nervous system by a low variability of heart rate and a high level of noradrenaline reflecting a dominant sympathetic axis. An anxiogenic and depressive profile and elevated cortisol levels are also often associated with this hyperarousal encountered in insomniacs. In addition, an alteration of the circadian rhythm seems to favor insomnia. Indeed, a decrease in core temperature and cortisol levels in the evening are primary mechanisms for sleep onset. A study showed an elevated sleep latency in individuals with this delayed circadian temperature rhythm. In the same study, a high wake-up time after sleep was associated with a high core temperature. Regarding cortisol, a smaller decline in cortisol and higher cortisol levels at the end of the day are associated with shorter sleep duration, lower sleep efficiency, and poor subjective sleep quality.

Although a first treatment of insomnia would be to find a good lifestyle and optimal sleep conditions, the majority of first-line remedies in the treatment of insomnia remain pharmacological today, through the short- or medium-term prescription of hypnotics, neuroleptics, anxiolytic benzodiazepines or some antidepressants.

If the practice of regular physical activity is now well known to improve overall health, what about sleep?

In 2017, the investigators published a study showing that an adapted Physical Activity (PA) program improved sleep in a population of young women. Overall, studies regarding the effects of exercise and physical activity are still recent but increasingly confirm the beneficial effects of PA on sleep.

Indeed, the literature reveals that there is an inverse correlation between the amount of PA and the severity of sleep disturbance.

In fact, it appears that regular physical activity decreases the recurrence of insomnia. In adults over 40 years of age with sleep disorders, a 10- to 16-week training program very significantly improved the qualitý of sleep and shortened sleep latency.

According to these same authors, PA thus poses as a reliable alternative to pharmacological management by showing a positive effect of PA on sleep.

However, further work is needed because the literature remains limited and sometimes contradictory. Moreover, the studies are most often based on subjective data with a great methodological disparity. The type of physical activity proposed in these different studies is very variable, ranging from aerobic exercise to muscle strengthening to yoga or other relaxation activities. To the best of our knowledge, there is no consensus on the intensity of exercise to be preferred to improve sleep.

1.1 Objectives

The objective of this project is therefore to evaluate the effects of an APA program in insomnia treatment therapies.

The follow-up of physiological and medical markers, throughout the APA program, will make it possible to observe the effect of the DK pulse intervention, to determine the mechanisms underlying the improvement of sleep by physical activity and thus to propose an optimization of the programs dedicated to the improvement of sleep.

The aim will be to extend this program from the local basin to the regional level (or even beyond) and to use the network of local APA structures to make this management as easy as possible for the patients.

1.1 General assumptions

The investigators hypothesize that the 12-week physical activity program will improve objective and subjective sleep in patients with insomnia. This improvement in sleep will be explained in part by a decrease in capillary cortisol levels, an increase in heart rate variability, a decrease in stress and/or an increase in circadian rhythm amplitude throughout the PA program.

This study is the second of three studies of the thesis of Pauline Baron (ULCO PhD student, financed by the Haut de France Region, in collaboration with health care services (Dr Aron).

The treating physicians of patients suffering from insomnia direct their patients to the dedicated sleep consultations for clinical assessment.

The sleep specialists propose physical activity within the framework of a prescription, after diagnostic and etiological assessments, and evaluation of the patients' symptoms, the comorbidities are evaluated in the same way as the motivation of the participants, and they ask the patients grouping the various criteria of inclusion/exclusion of the study if they wish to participate in a scientific study.

After the patient's informed consent, they are referred to Pauline BARON.

During the inclusion visit, the investigator reminds them in detail of the objectives and the course of the protocol. An information leaflet is given to each participant, who signs an authorization to participate in the study, accepting in particular the randomization of the groups (AP or control). The control group will not receive any intervention.

Adapted Physical Activities are programmed within the DK Pulse association, one of the 138 structures labelled Maison du Sport Santé (https://www.sports.gouv.fr/accueil-du-site/actualites/article/les-premieres-maisons-sport-sante-sont-desormais-connues ). The physical activity program is a 12-week program with 1 hour of aerobic type physical activity, of moderate intensity, 3 times a week (duration, frequency and intensity presumed to date according to the state of the art). The intensity of the physical activity (between 60 and 80% of VO2max) will be controlled by an RPE scale and a heart rate monitor.

The physical activity of the patients will be financially supported by the university.

As part of the care pathway, the investigators will evaluate different variables.

The variables will be measured at T0, T6 and T12 weeks for the 2 groups.

The following anthropometric and physiological parameters are measured:

Height (Tanita Leicester HR001 electronic height gauge); Body mass and composition (Tanita DC-360) Resting blood pressure (non-dominant arm, sitting position, Omron M3); White blood cell count measurement by capillary measurement (HemoCue® WBC DIFF Analyzer). Lack of sleep negatively affects the immune system. It is therefore interesting, especially in this health context, to measure the white blood cell count in patients suffering from insomnia, in order to prevent a possible infection.

Hair sampling for cortisol measurement (only at T0 and T12). The measurement of hair cortisol is essential in the care of a patient suffering from insomnia. It reflects the activity of the hypothalamic-pituitary-adrenal axis (HPA). An abnormally high level of cortisol and a disturbance of this axis can be a triggering or aggravating factor of insomnia.

Cardiorespiratory capacity on an ergometer (Monark e939): YMCA incremental submaximal test, up to 85% of the theoretical HR max, allowing to evaluate by projection the Maximum Aerobic Power (MAP) and the associated maximal O2 consumption (VO2max).

The evaluation is completed by taking an "e-celsius bodycap" capsule. This capsule allows continuous monitoring of the patient's core temperature. It is naturally eliminated in the stool. The follow-up of the central temperature is essential in the course of care of an insomniac patient. Indeed, it is one of the reflections of the biological clock and therefore allows us to observe the circadian rhythm and its amplitude.

At the end of this visit, patients will leave with :

an accelerometer, a Dreem research 2 headband a sleep diary and a physical activity log, a heart rate monitor (Polar H10).

During the following week, the participants equipped with the accelerometer on their wrist (non-dominant arm), fill out a daily sleep diary: wake-up and bedtime, naps.

They sleep with an EEG headband (Dreem 2 Research) that provides data for estimating the different stages of sleep.

The accelerometer allows to measure some sleep parameters such as total sleep time and time of nocturnal awakenings, the amount of physical activity and the associated energy expenditure (Actilife 6 software) during the 7 days. A PA diary will also be completed daily (type, intensity, duration).

Participants will wear the heart rate belt for 3 nights (from bedtime to sunrise) to record RR intervals (precise duration between each heartbeat) from which heart rate variability will be extracted (over a minimum interval of 5 hours). The frequency analysis of the RR signal allows to evaluate the respective activations of the sympathetic and parasympathetic nervous systems.

Each device is pre-programmed, no additional manipulation is necessary.

At the end of the 7 days, the participants return the equipment and answer several questionnaires:

On sleep and sleepiness: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI) and EPWORTH sleepiness scale On stress and quality of life: Perceived Stress Scale (PSS) and the Short Form Health Study (SF 36) On PA level: International Fitness Scale (IFIS)

03

Conditions studied

  • Exercise
  • Health Behavior
  • Sleep

Browse trials for

04

In context

Health Behavior Reclassified

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's planned enrollment of 25 is below the median of 150 across 824 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Universite du Littoral Cote d'Opale is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Compared within Health Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 18 to 60 with chronic insomnia (according to the 5 criteria of the Diagnostic and Statistical Manual) without any other associated sleep pathology (sleep apnea, restless legs syndrome, etc.)

Exclusion criteria

Exclusion Criteria:

  • Medical to physical activity Associated serious medical pathologies (cancer...) Night work, jet lag during the last month, young children > 30 Current use or \<3 months of psychoactive, hypnotic, stimulant or analgesic medications Alcohol or drug abuse
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
25 participants (estimated)

Study arms

  • No intervention
    control group

    no intervention

  • Experimental
    physical activity

    Behavioral: physical activity

Interventions

  • Behavioralphysical activity

    physical activity

07

What researchers measure

Primary outcomes

  1. subjective sleep change

    questionnaire insomnia severity index. The minimum score is 0 and the maximum is 28. Higher scores mean a worse outcome. A score higher than 14 is considered as a person with clinical insomnia.

    Time frame: before and after the 12 weeks

  2. objective sleep change

    Participants were fitted with an accelerometer on their wrist (non-dominant arm) for 7 days to assess the quantity and quality of their sleep

    Time frame: before and after the 12 weeks

Secondary outcomes

  1. circadian rythm change

    continuous temperature with BodyCap capsules

    Time frame: before and after the 12 weeks

  2. objective stress change

    cortisol level in hair

    Time frame: before and after the 12 weeks

  3. hearth rate variability change

    Time frame: before and after the 12 weeks

  4. physical capacity change

    Young Men's Christian Association (YMCA) submaximal VO2 test

    Time frame: before and after the 12 weeks

  5. subjective stress change

    Perceived Stress Scale- 10. The minimum score is 10 and the maximum is 50. Higher scores mean a worse outcome. A score higher than 27 is considered as a person with very high perceived stress level.

    Time frame: before and after the 12 weeks

08

Study locations

1 of 1 sites recruiting
  • University of littoral cote d'ople
    Dunkirk, France
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2021 (actual). Primary completion is estimated for Jan 2023, 16 months after the start.

Of 567 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 16 months is close to that.

Counting every sponsor, half of 585 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2021
First posted
Mar 24, 2022
StartActual
Sep 1, 2021
Primary completionEst.
Jan 1, 2023
CompletionEst.
Jan 1, 2023
Last update
Apr 5, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05294133
Lead sponsor
Universite du Littoral Cote d'Opale
Responsible party
Sponsor
First posted
Mar 24, 2022
Start date
Sep 1, 2021
Primary completion
Jan 1, 2023 (estimated)
Completion
Jan 1, 2023 (estimated)
Last update
Apr 5, 2022

Study contacts

Pauline BARON, Phd Student
Contact
pauline_baron@orange.fr
0673681126

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion